221 related articles for article (PubMed ID: 25393578)
1. Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.
Nie S; Yin H; Tan Z; Anderson MA; Ruffin MT; Simeone DM; Lubman DM
J Proteome Res; 2014 Dec; 13(12):6058-66. PubMed ID: 25393578
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis.
Nie S; Lo A; Wu J; Zhu J; Tan Z; Simeone DM; Anderson MA; Shedden KA; Ruffin MT; Lubman DM
J Proteome Res; 2014 Apr; 13(4):1873-84. PubMed ID: 24571389
[TBL] [Abstract][Full Text] [Related]
3. Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation.
Dimitrakopoulos L; Prassas I; Berns EMJJ; Foekens JA; Diamandis EP; Charames GS
Clin Chem Lab Med; 2017 Aug; 55(9):1291-1304. PubMed ID: 28157690
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteome analysis using isobaric peptide termini labeling (IPTL).
Arntzen MO; Koehler CJ; Treumann A; Thiede B
Methods Mol Biol; 2011; 753():65-76. PubMed ID: 21604116
[TBL] [Abstract][Full Text] [Related]
6. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
[TBL] [Abstract][Full Text] [Related]
7. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
8. Decoding the Effect of Isobaric Substitutions on Identifying Missing Proteins and Variant Peptides in Human Proteome.
Choong WK; Lih TM; Chen YJ; Sung TY
J Proteome Res; 2017 Dec; 16(12):4415-4424. PubMed ID: 28929764
[TBL] [Abstract][Full Text] [Related]
9. Quality control of single amino acid variations detected by tandem mass spectrometry.
Yi X; Wang B; An Z; Gong F; Li J; Fu Y
J Proteomics; 2018 Sep; 187():144-151. PubMed ID: 30012419
[TBL] [Abstract][Full Text] [Related]
10. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
11. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
12. Isobaric Labeling-Based LC-MS/MS Strategy for Comprehensive Profiling of Human Pancreatic Tissue Proteome.
Liu CW; Zhang Q
Methods Mol Biol; 2018; 1788():215-224. PubMed ID: 28986817
[TBL] [Abstract][Full Text] [Related]
13. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
14. A novel triplex isobaric termini labeling quantitative approach for simultaneously supplying three quantitative sources.
Jiang H; Yin H; Xie L; Zhang Y; Zhang L; Yang PY; Lu H
Anal Chim Acta; 2018 Feb; 1001():70-77. PubMed ID: 29291808
[TBL] [Abstract][Full Text] [Related]
15. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
[TBL] [Abstract][Full Text] [Related]
16. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery.
Yu KH; Barry CG; Austin D; Busch CM; Sangar V; Rustgi AK; Blair IA
J Proteome Res; 2009 Mar; 8(3):1565-76. PubMed ID: 19199705
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of single amino acid polymorphisms by targeted proteomics.
Su ZD; Sun L; Yu DX; Li RX; Li HX; Yu ZJ; Sheng QH; Lin X; Zeng R; Wu JR
J Mol Cell Biol; 2011 Oct; 3(5):309-15. PubMed ID: 22028381
[TBL] [Abstract][Full Text] [Related]
18. iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma.
Zhang Y; Cai Y; Yu H; Li H
Biomed Res Int; 2015; 2015():802153. PubMed ID: 26425554
[TBL] [Abstract][Full Text] [Related]
19. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
[TBL] [Abstract][Full Text] [Related]
20. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
